Biologics Market Trends, Opportunities & Competitive Landscape

0
19

 

Technological progress in biological drug manufacturing is creating new opportunities across the Biologics Market. The global industry was valued at USD 383.79 billion in 2025 and is projected to reach USD 423.36 billion in 2026 and USD 974.01 billion by 2035, according to Market Research Future. This represents a CAGR of 9.7% during 2026–2035. Manufacturers are increasingly investing in single-use bioreactors, continuous perfusion systems, and advanced process controls to improve production efficiency and reduce manufacturing costs. The expansion of biologics pipelines and growing demand for complex therapies are also encouraging investment in new production facilities and specialized manufacturing capabilities.

Single-use bioreactors accounted for 57.6% of manufacturing technology revenue in 2025, supported by their flexibility and reduced cleaning requirements. Continuous perfusion systems are expected to grow fastest in this category, with an 11.5% CAGR through 2035. Mammalian cell culture remained the leading production source, representing 65.8% of revenue, while plant-based systems are projected to expand at 11.7% CAGR. Companies are also exploring continuous manufacturing, modular facilities, and computational process design to strengthen production capacity. North America led the market with 37.2% of revenue in 2025, while Asia-Pacific is projected to achieve the highest regional growth rate at 10.5%. Major market participants include Roche/Genentech, Johnson & Johnson, AbbVie, Merck & Co., Novartis, Pfizer, Amgen, Sanofi, AstraZeneca, and Eli Lilly.

FAQs

  1. What is the largest manufacturing technology segment?
    Single-use bioreactors led the market with a 57.6% share in 2025.

  2. Which manufacturing technology is growing fastest?
    Continuous perfusion systems are projected to grow at an 11.5% CAGR.

  3. Which biological production source dominates?
    Mammalian cell culture accounted for 65.8% of market revenue in 2025.

  4. Why are manufacturers adopting single-use bioreactors?
    They offer production flexibility, faster changeovers, and reduced cleaning validation requirements.

  5. What is supporting investment in biologics manufacturing?
    Expanding therapeutic pipelines, capacity constraints, and the need for efficient production are encouraging investment.

Buscar
Categorías
Read More
Other
Fluorinated Chemical Market Industry Overview and Outlook
Fluorinated Chemical Market Report Overview The Fluorinated Chemical Market report is a...
By Vikas Hundekar 2026-03-18 12:13:18 0 685
Other
South Korea Electronic Grade Adhesives Market to Reach USD 585 Million by 2034 at 6.5% CAGR
  Market Overview According to 24ChemicalResearch, the South Korea Electronic Grade...
By Ayush Behra 2026-11-02 09:58:10 0 103
Health
AAT Test Market: Key Growth Drivers and Future Prospects
The outlook for the AAT Test Market is closely linked to efforts to strengthen diagnostic...
By Vaishnavi Chile 2026-10-26 08:01:41 0 135
Other
Drone Data Services Market Size, Share, Growth, Emerging Trends and Forecast Report
The Drone Data Services Market is rapidly emerging as one of the most transformative...
By Rachana Mmr 2026-06-03 11:25:45 0 3K
Other
Formaldehyde Free Fixing Agent Market Research Report: 2035 Outlook
Formaldehyde Free Fixing Agent Market Overview The Formaldehyde Free Fixing Agent...
By Vikas Hundekar 2026-08-18 11:31:26 0 314
Comunidad EDUCA https://comunidadeduca.com